- Paradoxically, although most of the seventeen major cannabis companies on the graph have had negative cumulative EBITDA surprises YTD in 2022, most of their stocks have outperformed the widely followed MSOS ETF. We have noted in the Viridian Deal Tracker how quarterly misses didn’t seem to matter to investors, so we decided to take a YTD look to see if investors were focused on a longer period.
